<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CFU-GM clonal growth was examined in bone marrow from patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) in the presence of Ara-C at 10(-8) M and 4 X 10(-8) M and the response compared to the effect on progenitors from <z:mpath ids='MPATH_458'>normal</z:mpath> subjects </plain></SENT>
<SENT sid="1" pm="."><plain>Seventy-three percent of marrow cultures from patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> showed colony growth below the 95% confidence limits for <z:mpath ids='MPATH_458'>normal</z:mpath> subjects in the presence of 10(-8) M Ara-C </plain></SENT>
<SENT sid="2" pm="."><plain>At 4 X 10(-8) M Ara-C 43% of marrow cultures had subnormal colony growth </plain></SENT>
<SENT sid="3" pm="."><plain>These results suggest that CFU-GM from patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> may have a greater than <z:mpath ids='MPATH_458'>normal</z:mpath> sensitivity to Ara-C </plain></SENT>
</text></document>